AB 804 — Medical waste: sharps waste.
Last action — From committee: Filed with the Chief Clerk pursuant to Joint Rule 56.
-
✓Introduced
-
2In Committee
-
3Passed Assembly
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill died with 2019-2020 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Existing law establishes a stewardship program, under which a manufacturer or distributor of covered drugs or sharps, or other entity defined to be covered by the bill, would be required to establish and implement, either on its own or as part of a group of covered entities through membership in a stewardship organization, a stewardship program for covered products, which is defined to include home-generated sharps waste. Existing law, for purposes of the stewardship program, defines "home-generated sharps waste" to mean hypodermic needles, pen needles, intravenous needles, lancets, and other devices that are used to penetrate the skin for the delivery of medications derived from a household, including a multifamily residence or household, subject to certain exclusions. Existing law requires a pharmaceutical manufacturer that sells or distributes a medication in California that is usually intended to be self-injected at home through the use of a hypodermic needle, pen needle, intravenous needle, or any other similar device, to annually submit to the Department of Resources Recycling and Recovery and post on its internet website a plan that describes how the manufacturer supports the safe collection and proper disposal of the waste devices. This bill would provide that a pharmaceutical manufacturer is not required to submit or post that annual plan if the devices it uses for the injection of that medication are covered products, including home-generated sharps waste, pursuant to the provisions establishing the above-mentioned stewardship program.
Bill Text
What changed in the latest version
1 added · 1 removed1 line(s) added, 1 removed.
Bill Number Bill Keyword Home Bill Information California Law Publications Other Resources My Subscriptions My Favorites Bill Information >> Bill Search >> Text Bill TextBillText Information PDF2 Bill PDF |Add To My Favorites | Version:
View plain text versions (2)
- Introduced 02/20/19 - Introduced Current pdf February 20, 2019
- AB804 View text html
Action History
-
From committee: Filed with the Chief Clerk pursuant to Joint Rule 56.
-
Died pursuant to Art. IV, Sec. 10(c) of the Constitution.
-
Referred to Com. on E.S. & T.M.
-
From printer. May be heard in committee March 23.
-
Read first time. To print.
Sponsors
- Ting · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 121 not signed on
Sponsors (1)
- Ting
Co-sponsors (0)
None.
Not signed on (121)
121 members have not signed on to this bill.
Show all 121 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does AB 804 do?
- Existing law establishes a stewardship program, under which a manufacturer or distributor of covered drugs or sharps, or other entity defined to be covered by the bill, would be required to establish and implement, either on its own or as part of a group of covered entities through membership in a stewardship organization, a stewardship program for covered products, which is defined to include home-generated sharps waste. Existing law, for purposes of the stewardship program, defines "home-generated sharps waste" to mean hypodermic needles, pen needles, intravenous needles, lancets, and other devices that are used to penetrate the skin for the delivery of medications derived from a household, including a multifamily residence or household, subject to certain exclusions. Existing law requires a pharmaceutical manufacturer that sells or distributes a medication in California that is usually intended to be self-injected at home through the use of a hypodermic needle, pen needle, intravenous needle, or any other similar device, to annually submit to the Department of Resources Recycling and Recovery and post on its internet website a plan that describes how the manufacturer supports the safe collection and proper disposal of the waste devices. This bill would provide that a pharmaceutical manufacturer is not required to submit or post that annual plan if the devices it uses for the injection of that medication are covered products, including home-generated sharps waste, pursuant to the provisions establishing the above-mentioned stewardship program.
- Who sponsors AB 804?
- AB 804 is sponsored by Ting.
- What is the current status of AB 804?
- This bill died with 2019-2020 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track AB 804?
- Track AB 804 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on AB 804
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of AB 804
Last checked for changes 2 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →